AAV-Containing Exosomes as a Novel Vector for Improved Gene Delivery to Lung Cancer Cells

被引:29
作者
Liu, Bin [1 ,2 ]
Li, Zhiqing [3 ]
Huang, Shi [4 ]
Yan, Biying [1 ]
He, Shan [3 ]
Chen, Fengyuan [5 ]
Liang, Yaxuan [1 ]
机构
[1] Beijing Normal Univ Zhuhai, Ctr Biol Sci & Technol, Adv Inst Nat Sci, Zhuhai, Peoples R China
[2] Capital Med Univ, Dept Cellular & Mol Biol, Beijing Chest Hosp, Beijing TB & Thorac Tumor Res Inst, Beijing, Peoples R China
[3] Southern Med Univ, Nanfang Hosp, Dept Burns, Guangzhou, Peoples R China
[4] Anhui Univ Chinese Med, Hefei, Peoples R China
[5] Anhui Univ Chinese Med, Sch Integrated Chinese & Western Med, Dept Pathol, Hefei, Peoples R China
基金
中国国家自然科学基金;
关键词
AAV-exosome; AAV; lung cancer; neutralizing antibody; gene therapy; exosome; extracellular vesicles; NEUTRALIZING ANTIBODIES; VIRUS; ROBUST;
D O I
10.3389/fcell.2021.707607
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Lung carcinoma is the most common type of cancer and the leading cause of cancer-related death worldwide. Among the numerous therapeutic strategies for the treatment of lung cancer, adeno-associated virus (AAV)-mediated gene transfer has been demonstrated to have the potential to effectively suppress tumor growth or reverse the progression of the disease in a number of preclinical studies. AAV vector has a safety profile; however, the relatively low delivery efficacy to particular subtypes of lung carcinoma has limited its prospective clinical translation. Exosomes are nanosized extracellular vesicles secreted from nearly all known cell types. Exosomes have a membrane-enclosed structure carrying a range of cargo molecules for efficient intercellular transfer of functional entities, thus are considered as a superior vector for drug delivery. In the present study, we developed a novel strategy to produce and purify AAV-containing exosomes (AAVExo) from AAV-packaging HEK 293T cells. The cellular uptake capacity of exosomes assisted and enhanced AAV entry into cells and protected AAV from antibody neutralization, which was a serious challenge for AAV in vivo application. We tested a list of lung cancer cell lines representing non-small-cell lung cancer and small-cell lung cancer and found that AAVExo apparently improved the gene transfer efficiency compared to conventional AAV vector. Our in vitro results were supported in vivo in a lung cancer xenograft rodent model. Additionally, we evaluated the gene delivery efficiency in the presence of neutralizing antibody on lung cancer cells. The results demonstrated that AAVExo-mediated gene transfer was not impacted, while the AAV vectors were significantly blocked by the neutralizing antibody. Taken together, we established an efficient methodology for AAVExo purification, and the purified AAVExo largely enhanced gene delivery to lung cancer cells with remarkable resistance to antibody neutralization.
引用
收藏
页数:12
相关论文
共 42 条
[1]  
Administration U.S.F.a.D, 2019, ZOLGENSMA SUMM BAS R
[2]  
Administration U.S.F.a.D, 2017, CYB PAINT
[3]   Low pH increases the yield of exosome isolation [J].
Ban, Jae-Jun ;
Lee, Mijung ;
Im, Wooseok ;
Kim, Manho .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 461 (01) :76-79
[4]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[5]   In vivo engineering of lymphocytes after systemic exosome-associated AAV delivery [J].
Breuer, Cort B. ;
Hanlon, Killian S. ;
Natasan, Jeya-shree ;
Volak, Adrienn ;
Meliani, Amine ;
Mingozzi, Federico ;
Kleinstiver, Benjamin P. ;
Moon, James J. ;
Maguire, Casey A. .
SCIENTIFIC REPORTS, 2020, 10 (01)
[6]   Effect of bortezomib on the efficacy of AAV9.SERCA2a treatment to preserve cardiac function in a rat pressure-overload model of heart failure [J].
Chaanine, A. H. ;
Nonnenmacher, M. ;
Kohlbrenner, E. ;
Jin, D. ;
Kovacic, J. C. ;
Akar, F. G. ;
Najjar, R. J. ;
Weber, T. .
GENE THERAPY, 2014, 21 (04) :379-386
[7]   Comparative analysis of the transduction efficiency of five adeno associated virus serotypes and VSV-G pseudotype lentiviral vector in lung cancer cells [J].
Chen, Chiachen ;
Akerstrom, Victoria ;
Baus, James ;
Lan, Michael S. ;
Breslin, Mary B. .
VIROLOGY JOURNAL, 2013, 10
[8]   AAV-Mediated angiotensin 1-7 overexpression inhibits tumor growth of lung cancer in vitro and in vivo [J].
Chen, Xinglu ;
Chen, Sansan ;
Pei, Nana ;
Mao, Yingying ;
Wang, Shengyao ;
Yan, Renhe ;
Bai, Na ;
Li, Andrew ;
Zhang, Yanling ;
Du, Hongyan ;
Chen, Baihong ;
Sumners, Colin ;
Li, Jinlong ;
Li, Hongwei .
ONCOTARGET, 2017, 8 (01) :354-363
[9]  
European Medicines Agency, 2012, PRESS REL EUR MED AG
[10]   A pathogenic picornavirus acquires an envelope by hijacking cellular membranes [J].
Feng, Zongdi ;
Hensley, Lucinda ;
McKnight, Kevin L. ;
Hu, Fengyu ;
Madden, Victoria ;
Ping, LiFang ;
Jeong, Sook-Hyang ;
Walker, Christopher ;
Lanford, Robert E. ;
Lemon, Stanley M. .
NATURE, 2013, 496 (7445) :367-+